E Corcoran - Phibro Animal Independent Director
| PB8 Stock | EUR 20.00 0.00 0.00% |
Insider
E Corcoran is Independent Director of Phibro Animal Health since 2008.
| Age | 72 |
| Tenure | 17 years |
| Phone | 201 329 7300 |
| Web | https://www.pahc.com |
Phibro Animal Management Efficiency
The company has return on total asset (ROA) of 0.0532 % which means that it generated a profit of $0.0532 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1428 %, meaning that it generated $0.1428 on every $100 dollars invested by stockholders. Phibro Animal's management efficiency ratios could be used to measure how well Phibro Animal manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Torsten Leue | Talanx AG | 57 | |
| Sven Pettersson | SIVERS SEMICONDUCTORS AB | 60 | |
| Dag Sigurd | SIVERS SEMICONDUCTORS AB | 73 | |
| Christopher Lohmann | Talanx AG | 55 | |
| Ingrid Engstrom | SIVERS SEMICONDUCTORS AB | 59 | |
| Trond Christophersen | Norsk Hydro ASA | 51 | |
| JeanJacques Henchoz | Talanx AG | 59 | |
| Ravi Mallela | NMI Holdings | 53 | |
| Arvid Moss | Norsk Hydro ASA | 65 | |
| Hilde Aasheim | Norsk Hydro ASA | 65 | |
| Paul Warton | Norsk Hydro ASA | 62 | |
| FCA FCA | Superior Plus Corp | 68 | |
| Mike Taylor | Identiv | N/A | |
| Erik Fallstrom | SIVERS SEMICONDUCTORS AB | 56 | |
| MBA MBA | Superior Plus Corp | 70 | |
| Therese Holm | Norsk Hydro ASA | N/A | |
| Robert Green | SIVERS SEMICONDUCTORS AB | 60 | |
| Pal Kildemo | Norsk Hydro ASA | 39 | |
| Rick Carron | Superior Plus Corp | N/A | |
| Jan Wicke | Talanx AG | 55 | |
| Erik Wiklund | SIVERS SEMICONDUCTORS AB | 49 | |
Management Performance
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0532 |
Phibro Animal Health Leadership Team
Elected by the shareholders, the Phibro Animal's board of directors comprises two types of representatives: Phibro Animal inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Phibro. The board's role is to monitor Phibro Animal's management team and ensure that shareholders' interests are well served. Phibro Animal's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Phibro Animal's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ramon Fuenmayor, Pres Region | ||
| Larry Miller, Chief Operating Officer | ||
| Thomas Dagger, Senior Vice President General Counsel, Corporate Secretary | ||
| Jonathan Bendheim, Director and President MACIE Region and General Manager of Israel Operations | ||
| E Corcoran, Independent Director | ||
| Damian Finio, Chief Officer | ||
| Jean Filippi, Pres Region | ||
| Richard Johnson, Chief Financial Officer | ||
| Gerald Carlson, Independent Director | ||
| Mary Malanoski, Independent Director | ||
| Rob Aukerman, President North America Region | ||
| Jack Bendheim, Chairman of the Board, President, Chief Executive Officer, Director | ||
| Daniel Bendheim, Executive Vice President, Corporate Strategy and Director | ||
| Anthony Andolino, Vice President - Finance, Treasurer | ||
| Sam Gejdenson, Independent Director | ||
| Lisa Escudero, Senior Vice President of Human Resources | ||
| Carol Wrenn, Independent Director |
Phibro Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Phibro Animal a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0532 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 977.72 M | |||
| Shares Outstanding | 20.34 M | |||
| Shares Owned By Insiders | 0.54 % | |||
| Shares Owned By Institutions | 99.46 % | |||
| Price To Earning | 21.51 X | |||
| Price To Book | 2.32 X |
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Additional Information and Resources on Investing in Phibro Stock
When determining whether Phibro Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phibro Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phibro Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phibro Animal Health Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Phibro Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.